Healthcare

Transdermal Skin Patches Global Market 2024 – By Size, Share, Trends, Demand, Forecast To 2033 | Novartis, Hisamitsu Pharmaceutical Co., Inc., Henan Lingrui Pharmaceutical

The transdermal skin patches market size is expected to see steady growth in the next few years. It will grow to $9.02 billion in 2028 at a compound annual growth rate (CAGR) of 4.1%. The growth in the forecast period can be attributed to the increase in smoking cessation, the rapid growth in the aging population, the increasing healthcare expenditure and the increase in cardiovascular diseases. Major trends in the forecast period include technological advancement in transdermal skin patches, advancements in diabetes transdermal patches, robust research and development activities, product innovation, collaborations and partnerships, wearable skin patches, advancements in microneedle patches for vaccination and new iontophoresis patches.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/transdermal-skin-patche-global-market-report

Segmentation & Regional Insights
The transdermal skin patches market covered in this report is segmented –
1) By Product: Matrix, Drug In Adhesive, Reservoir, Vapor
2) By Type: Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Estradiol Transdermal Patch, Clonidine Transdermal Patch, Testosterone Transdermal Patch, Other Types
3) By Distribution Channel: Pain Relief, Nicotine Cessation,Hormone Replacement Therapy, Neurological Disorders, Cardiovascular Disorders, Other Applications

North America was the largest region in the global transdermal skin patches market in 2023. Middle East is expected to be the fastest growing region in the transdermal skin patches market report during the forecast period. The regions covered in the transdermal skin patches market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2829&type=smp

Major Driver Impacting Market Growth
The increasing prevalence of cardiovascular disease is expected to propel the growth of the transdermal skin patches market going forward. Cardiovascular diseases are ailments that have an impact on the heart and blood vessels. The development of fatty deposits inside the arteries (atherosclerosis) and a higher risk of blood clots are typically connected with it. Transdermal skin patches are used to prevent episodes of angina (chest pain) in people who have coronary artery disease (narrowing of the blood vessels that supply blood to the heart). These are also used to improve bioavailability for the treatment of heart failure. For instance, in May 2023, according to the Centers for Disease Control and Prevention, a US-based public health agency, about 695,000 people in the United States died from heart disease in 2021—that’s 1 in every 5 deaths. Coronary heart disease is the most common type of heart disease, killing 375,476 people in 2021. Therefore, the increasing prevalence of cardiovascular disease is driving the growth of the transdermal skin patches market.

Key Industry Players
Major companies operating in the transdermal skin patches market report are Novartis, Hisamitsu Pharmaceutical Co., Inc, Henan Lingrui Pharmaceutical, Teva Phamaceuticals, Luye Pharma Group Ltd, Purdue Pharma L.P., Nitto Denko Corporation, AdhexPharma, Noven Pharmaceuticals, Teikoku Pharma, Mylan Pharmaceuticals Inc, 3M Company, Acrux Ltd, Access Pharmaceuticals Inc, Rusan Pharma, Glenmark Pharmaceuticals, Cipla Ltd, Mundipharma, Dr Reddy’s Laboratories, Chattem, Clarity Medical, Welcare Industries S.P. A, F.L. Medical S.r.l, Empire MEDICAL UK LTD, Europlaz Technologies Ltd, Zentiva, Alfa-Med LLC, Medplant LLC, Medical-Łomża Sp. z o.o., P.H.U. Medical, ProVeterináře, Panop CZ, Allergan Inc., Johnson & Johnson, Boehringer Ingelheim GmbH, Bayer AG, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Echo Therapeutics Inc, Endo Pharmaceuticals Inc.

The transdermal skin patches market report table of contents includes:
1. Executive Summary
2. Transdermal Skin Patches Market Characteristics
3. Transdermal Skin Patches Market Trends And Strategies
4. Transdermal Skin Patches Market – Macro Economic Scenario
5. Global Transdermal Skin Patches Market Size and Growth
…………………………
32. Global Transdermal Skin Patches Market Competitive Benchmarking
33. Global Transdermal Skin Patches Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Transdermal Skin Patches Market
35. Transdermal Skin Patches Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Good PR News